Stock ANIX ANIXA BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Anixa Biosciences, Inc.

Equities

ANIX

US03528H1095

Market Closed - Nasdaq
Other stock markets
 21:00:00 10/05/2024 BST 		5-day change 1st Jan Change
3 USD +4.53% Intraday chart for Anixa Biosciences, Inc. +2.04% -22.68%
05-08 Anixa Biosciences, Inc. Enters into a Joint Development Agreement with Cleveland Clinic to Develop Novel Vaccines for Various Cancer Types CI
04-18 Anixa Biosciences Welcomes Sanjay Juneja to Its Cancer Business Advisory Board CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Anixa Biosciences Welcomes Sanjay Juneja to Its Cancer Business Advisory Board
CI
Anixa Biosciences, Inc. Appoints Mark A. Goldberg, Md, to Its Cancer Business Advisory Board
CI
Anixa Biosciences, Inc. Establishes Cancer Business Advisory Board
CI
Anixa Biosciences Announces Formation of Breast Cancer Clinical Advisory Board
CI
Anixa Biosciences, Inc. Announces Management Changes
CI
Anixa Biosciences, Inc. Appoints Dr. Pamela Garzone as Chief Development Officer
CI
Insider Trends: 90-Day Buying Trend Extended with Insider Purchase of Anixa Biosciences Stock
MT
John Monahan and David Cavalier Not to Stand for Re-Election At Anixa Biosciences, Inc
CI
Insider Trends: 90-Day Buying Trend Extended with Insider Purchase of Anixa Biosciences Stock
MT
Anixa Biosciences, Inc. Announces Appointment of Emanuele Ostuni to its Scientific Advisory Board
CI
Anixa Biosciences, Inc. Appoints Emily Gottschalk as Director
CI
Anixa Biosciences, Inc. Appoints Thomas Schlumpberger as Executive Vice President of Diagnostics to Head Liquid Biopsy Development and Commercialization Efforts
CI
Anixa Biosciences Names Dr. Ian H. Frazer to Scientific Advisory Board
CI
Anixa Biosciences, Inc. Announces Scientific Advisory Board Changes
CI
Anixa Biosciences, Inc. Appoints David Cavalier as Director
CI
ITUS Corporation will Change its Name to Anixa Biosciences, Inc
CI
ITUS Corporation Appoints Lewis H. Titterton, Existing Member of the Board of Directors, as Lead Independent Director
CI
ITUS Corporation Appoints Lew Titterton to its Board of Directors
CI
ITUS Corporation Announces Management Changes
CI
ITUS Corporation Appoints Amit Kumar to American Cancer Society National Board of Directors
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ANIX Stock
  4. News Anixa Biosciences, Inc.
  5. Insiders